Your browser doesn't support javascript.
loading
Analysis of the Efficacy and Recurrence of Omalizumab Use in the Treatment of Chronic Spontaneous Urticaria and Chronic Inducible Urticaria.
Yu, Rentao; Qian, Weilu; Zheng, Qiu; Xiong, Jianxia; Chen, Shuang; Chen, Aijun; Chen, Jin; Fang, Sheng; Huang, Kun; Cai, Tao.
Afiliação
  • Yu R; Department of Dermatology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
  • Qian W; Department of Dermatology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
  • Zheng Q; Department of Dermatology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
  • Xiong J; Department of Dermatology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
  • Chen S; Department of Dermatology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
  • Chen A; Department of Dermatology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
  • Chen J; Department of Dermatology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
  • Fang S; Department of Dermatology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
  • Huang K; Department of Dermatology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
  • Cai T; Department of Dermatology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Int Arch Allergy Immunol ; 184(7): 643-655, 2023.
Article em En | MEDLINE | ID: mdl-36996780
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Urticária / Antialérgicos / Urticária Crônica Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Int Arch Allergy Immunol Assunto da revista: ALERGIA E IMUNOLOGIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Urticária / Antialérgicos / Urticária Crônica Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Int Arch Allergy Immunol Assunto da revista: ALERGIA E IMUNOLOGIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China